LivaNova LIVN
NASDAQ LIVN
$78.04 -2.80 (-3.47%)
At close: Aug 20, 2026 · 1:25 PM UTC

LivaNova (LIVN) Total Current Liabilities (2015 - 2026)

LivaNova (LIVN) posted Total Current Liabilities of $762.5 million for Q1 2026, down 5.64% sequentially from $808.1 million in Q4 2025, and up 2.82% YoY from $741.6 million in Q1 2025.

LivaNova (LIVN) Total Current Liabilities (2015 - 2026) Analysis & Trends

LivaNova has reported Total Current Liabilities for 12 years, with the latest figure at $762.5 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 2.82% year-over-year to $762.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $762.5 million (up 2.82% YoY) and the FY2025 annual result came in at $808.1 million, up 106.08% from the prior year.
  • Total Current Liabilities eased to $762.5 million in Q1 2026 per LIVN's latest filing, from $808.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $827.6 million in Q3 2025 and troughed at $263.9 million in Q2 2022.
  • A 5-year average of $453.3 million and a median of $324.4 million in 2024 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 62.42% in 2022, then soared 172.98% in 2025.
  • Over 5 years, Total Current Liabilities stood at $297.4 million in 2022, then gained by 12.64% to $335.0 million in 2023, then climbed by 17.06% to $392.1 million in 2024, then surged by 106.08% to $808.1 million in 2025, then retreated by 5.64% to $762.5 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $762.5 million, $808.1 million, and $827.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 198.81 Bn 193.21 Bn 7.27 Bn 17.81 Bn
2 Stryker 127.76 Bn 124.28 Bn 4.50 Bn 6.68 Bn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn 11.66 Bn
4 Boston Scientific 73.25 Bn 72.71 Bn 3.85 Bn 6.43 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 1.51 Bn
6 Dexcom 34.43 Bn 32.49 Bn 830.00 Mn 2.36 Bn
7 GE HealthCare Technologies 33.88 Bn 31.77 Bn 2.18 Bn 8.30 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 8.63 Bn
9 Steris 23.11 Bn 22.63 Bn 684.20 Mn 1.28 Bn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn 707.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 707.00 Mn
Mar 31, 2026 762.48 Mn
Dec 31, 2025 808.07 Mn
Sep 30, 2025 827.59 Mn
Jun 30, 2025 827.10 Mn
Mar 31, 2025 741.57 Mn
Dec 31, 2024 392.13 Mn
Sep 30, 2024 324.40 Mn
Jun 30, 2024 302.99 Mn
Mar 31, 2024 327.77 Mn
Dec 31, 2023 334.98 Mn
Sep 30, 2023 295.40 Mn
Jun 30, 2023 288.16 Mn
Mar 31, 2023 316.13 Mn
Dec 31, 2022 297.40 Mn
Sep 30, 2022 288.02 Mn
Jun 30, 2022 263.89 Mn
Mar 31, 2022 307.91 Mn
Dec 31, 2021 696.97 Mn
Sep 30, 2021 658.47 Mn